However, the suboptimal specificity of PSA for prostate cancer leads to many unnecessary biopsies as well as to detection of many clinically insignificant prostate cancers, which left untreated would not give rise to any symptoms in the man’s normal lifespan5. This evidence concerns the gene KLK3 and Familial prostate cancer.